| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $3.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $7.48 | $747,500.00 | -6.2% | -19.9% | -31.2% | |
| Jun 6, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $8.71 | $871,000.00 | -6.4% | -32.3% | -39.1% | |
| May 2, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $8.10 | $810,000.00 | -3.8% | -6.7% | -35.2% | |
| Apr 4, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 130,000 | $8.93 | $1,160,900.00 | -6.4% | -15.8% | -51.4% | |
| Mar 28, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 65,000 | $10.10 | $656,500.00 | -5.9% | -12.1% | -41.7% | |
| Mar 6, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 61,319 | $11.73 | $719,504.90 | -5.2% | -25.7% | -44.9% | |
| Feb 7, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 48,272 | $9.22 | $444,980.95 | -5.9% | -3.7% | -20.7% | |
| Jan 3, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 55,853 | $9.50 | $530,567.33 | -6.6% | -9.5% | -25.6% | |
| Dec 6, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 59,829 | $7.49 | $448,394.42 | -7.0% | +60.5% | -11.2% | |
| Nov 1, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 62,177 | $5.17 | $321,300.93 | -6.9% | +93.3% | +24.2% |